Emergent Biosolutions (EBS)Director sold ~$57K

~$57K

Approx. value · 10K sh @ $5.73

44K

Holds after · shares reported

Traded

Mar 12, 2025

Filed

Mar 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 12, 2025 · this disclosureInsiderDirector sold ~$57K of EBS shares in the open market

What came next

1. Mar 12, 2025InsiderDirector sold ~$204K of EBS shares in the open market
2. May 13, 2025InsiderCEO purchased ~$350K of EBS shares in the open market
3. May 23, 2025InsiderDirector sold ~$49K of EBS shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Emergent Biosolutions

For Emergent Biosolutions, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EBS page.

Other recent filings by Kathryn C Zoon, Director

• SEC Form 4 at Emergent Biosolutions (EBS)Aug 18, 2025

The full history of Kathryn C Zoon, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Emergent Biosolutions

• SEC Form 144Oct 7, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 4Oct 5, 2026
• USAspending.gov award recordJun 4, 2026
• USAspending.gov award recordApr 28, 2026
• USAspending.gov award recordMar 4, 2026

Everything OQRO holds on this company is on its EBS page.